Astrazeneca (LON:AZN) cover image
960 Reads (2 mins read)

What lies in store for the Astrazeneca share price?

22nd Jul by Ben Hobson

It has been a rollercoaster year for UK shares, with coronavirus sending a wave of uncertainty through the economy. For investors in well known companies like Astrazeneca (LON:AZN), the question is: where will prices go from here?

Astrazeneca is part of an elite club of UK shares which all have market capitalisations in excess of £1.0 billion. The stock is currently valued at £118,734m

This special group of large-caps has a powerful presence in the investment funds and pension portfolios of millions of savers. So their performance is closely watched.

Over the past 12 months, the Astrazeneca share price has seen an absolute move of 41.8%

Bearing in mind that volatility over the past year has impacted on some sectors worse than others, it’s also worth thinking about that performance in the context of the overall market.

On a relative basis, shares in Astrazeneca have moved by 69.0% over the past year and by 43.8% over the past six months.

But what now?

GET MORE DATA-DRIVEN INSIGHTS INTO LON:AZN »

Do analysts rate it as a buy, sell or hold?

Regardless of recent performance, the main question for investors is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news is that analysts generally understand the market's biggest businesses better than most, so they are well-placed to make predictions. That shows up in their Buy, Hold and Sell recommendations.

Among the analysts covering Astrazeneca, there are currently:

  • 8 Buy recommendations
  • 2 Hold recommendations
  • 1 Sell recommendations

With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.

It's also worth looking at the profile of the stock to understand whether it has strong positive exposure to important factors like Quality, Value and Momentum. On that basis, Stockopedia currently classifies Astrazeneca as  high flyer. You can read more about what that means here.

What does this mean for potential investors?

Astrazeneca is one of the most closely watched shares in the market. But while price trends and broker recommendations can give you an idea about the sentiment around a stock, they can't tell you everything. 

To get a better understanding of the overall investment case, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Astrazeneca that you can find out about here.

Share this article
As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.
Share Price
7943p
Change Today
-0.15%
Astrazeneca ( )

Stockopedia is here to help individual investors beat the markets by being the very best in stock analysis, research & community. Take a 30 day free trial of our extensive multi-award winning service and find out why more than ten thousand global investors can't live without it.

© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.